PRKN and Parkinson disease: Some studies have established monkey models of PD at different ages using CRISPR/Cas9 and found that the phosphorylation of Parkin is important for neuroprotection in PD; similarly, CRISPR/Cas9 could be used to study PTEN in PD in future research (Han et al., 2024).